Primary human breast cancer cells can also respond to CXCL12 [133] and in breast cancer patients, high levels of CXCR4 expression have been correlated with lymph node metastasis in invasive ductal carcinoma and associated with poor overall survival [137,138]. Here, CXCL12 is linked to breast carcinoma.